Literature DB >> 15583294

Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa.

Barry Curran1, Daniel Jonas, Hajo Grundmann, Tyrone Pitt, Christopher G Dowson.   

Abstract

A multilocus sequence typing (MLST) scheme has been developed for Pseudomonas aeruginosa which provides molecular typing data that are highly discriminatory and electronically portable between laboratories. MLST data confirm the data from previous studies that suggest that P. aeruginosa is best described as nonclonal but as having an epidemic population. The index of association was 0.17, indicating a freely recombining population; however, there was evidence of clusters of closely related strains or clonal complexes among the members of this population. It is apparent that the sequence types (STs) from single isolates, representing each of the present epidemic clones in the United Kingdom from Liverpool, Manchester, and the West Midlands, are not closely related to each other. This suggests distinct evolutionary origins for each of these epidemic clones in the United Kingdom. Furthermore, these clones are distinct from European clone C. Comparison of the results of MLST with those of toxA typing and serotyping revealed that strains with identical STs may possess different toxA types and diverse serotypes. Given that recombination is important in the population of P. aeruginosa, the lack of a linkage between toxA type and serotype is not surprising and reveals the strength of the MLST approach for obtaining a better understanding of the epidemiology of P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15583294      PMCID: PMC535286          DOI: 10.1128/JCM.42.12.5644-5649.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Sequence type analysis and recombinational tests (START).

Authors:  K A Jolley; E J Feil; M S Chan; M C Maiden
Journal:  Bioinformatics       Date:  2001-12       Impact factor: 6.937

Review 2.  Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

Authors:  G Döring; S P Conway; H G Heijerman; M E Hodson; N Høiby; A Smyth; D J Touw
Journal:  Eur Respir J       Date:  2000-10       Impact factor: 16.671

3.  Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives.

Authors:  S J McCallum; M J Gallagher; J E Corkill; C A Hart; M J Ledson; M J Walshaw
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

4.  Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors.

Authors:  J A Lomholt; K Poulsen; M Kilian
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

5.  Large chromosomal inversions occur in Pseudomonas aeruginosa clone C strains isolated from cystic fibrosis patients.

Authors:  U Römling; K D Schmidt; B Tümmler
Journal:  FEMS Microbiol Lett       Date:  1997-05-01       Impact factor: 2.742

Review 6.  Molecular epidemiology of Pseudomonas aeruginosa.

Authors:  David P Speert
Journal:  Front Biosci       Date:  2002-10-01

7.  European-wide distribution of Pseudomonas aeruginosa clone C.

Authors:  S D Dinesh; H Grundmann; T L Pitt; U Römling
Journal:  Clin Microbiol Infect       Date:  2003-12       Impact factor: 8.067

8.  Pseudomonas aeruginosa displays an epidemic population structure.

Authors:  Jean-Paul Pirnay; Daniel De Vos; Christel Cochez; Florence Bilocq; Alain Vanderkelen; Martin Zizi; Bart Ghysels; Pierre Cornelis
Journal:  Environ Microbiol       Date:  2002-12       Impact factor: 5.491

9.  Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada.

Authors:  David P Speert; Maureen E Campbell; Deborah A Henry; Ruth Milner; Fatma Taha; Anna Gravelle; A George F Davidson; Lawrence T K Wong; Eshwar Mahenthiralingam
Journal:  Am J Respir Crit Care Med       Date:  2002-10-01       Impact factor: 21.405

10.  Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa.

Authors:  David H Spencer; Arnold Kas; Eric E Smith; Christopher K Raymond; Elizabeth H Sims; Michele Hastings; Jane L Burns; Rajinder Kaul; Maynard V Olson
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

View more
  171 in total

1.  The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility.

Authors:  Veronica N Kos; Maxime Déraspe; Robert E McLaughlin; James D Whiteaker; Paul H Roy; Richard A Alm; Jacques Corbeil; Humphrey Gardner
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections.

Authors:  Ashley E Warren; Carla M Boulianne-Larsen; Christine B Chandler; Kami Chiotti; Evgueny Kroll; Scott R Miller; Francois Taddei; Isabelle Sermet-Gaudelus; Agnes Ferroni; Kathleen McInnerney; Michael J Franklin; Frank Rosenzweig
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

3.  Emergence of a mutL mutation causing multilocus sequence typing-pulsed-field gel electrophoresis discrepancy among Pseudomonas aeruginosa isolates from a cystic fibrosis patient.

Authors:  María García-Castillo; Luis Máiz; María-Isabel Morosini; Mercedes Rodríguez-Baños; Lucrecia Suarez; Ana Fernández-Olmos; Fernando Baquero; Rafael Cantón; Rosa del Campo
Journal:  J Clin Microbiol       Date:  2012-02-08       Impact factor: 5.948

4.  A new highly discriminatory multiplex capillary-based MLVA assay as a tool for the epidemiological survey of Pseudomonas aeruginosa in cystic fibrosis patients.

Authors:  D Sobral; P Mariani-Kurkdjian; E Bingen; H Vu-Thien; K Hormigos; B Lebeau; F Loisy-Hamon; A Munck; G Vergnaud; C Pourcel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-11       Impact factor: 3.267

5.  Infrequent finding of metallo-β-lactamase VIM-2 in carbapenem-resistant Pseudomonas aeruginosa strains from Croatia.

Authors:  Sanda Sardelic; Branka Bedenic; Céline Colinon-Dupuich; Stjepan Orhanovic; Zrinka Bosnjak; Vanda Plecko; Benoit Cournoyer; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2012-02-27       Impact factor: 5.191

6.  Intercontinental dissemination of IMP-13-producing Pseudomonas aeruginosa belonging in sequence type 621.

Authors:  Gisela Santella; Simona Pollini; Jean-Denis Docquier; Ana Irina Mereuta; Gabriel Gutkind; Gian Maria Rossolini; Marcela Radice
Journal:  J Clin Microbiol       Date:  2010-09-15       Impact factor: 5.948

7.  Multilocus sequence types of carbapenem-resistant Pseudomonas aeruginosa in Singapore carrying metallo-beta-lactamase genes, including the novel bla(IMP-26) gene.

Authors:  Tse Hsien Koh; Cheng Teng Khoo; Thuan Tong Tan; Mohamed Amir Bin Mohamed Arshad; Li Ping Ang; Lee Jin Lau; Li-Yang Hsu; Eng Eong Ooi
Journal:  J Clin Microbiol       Date:  2010-05-12       Impact factor: 5.948

8.  The colistin-only-sensitive Brazilian Pseudomonas aeruginosa clone SP (sequence type 277) is spread worldwide.

Authors:  Erica Lourenço da Fonseca; Fernanda dos Santos Freitas; Ana Carolina Paulo Vicente
Journal:  Antimicrob Agents Chemother       Date:  2010-04-05       Impact factor: 5.191

9.  Regional spread of Pseudomonas aeruginosa ST357 producing IMP-7 metallo-β-lactamase in Central Europe.

Authors:  Jaroslav Hrabák; Dana Cervená; Radoslaw Izdebski; Wojciech Duljasz; Marek Gniadkowski; Marta Fridrichová; Pavla Urbásková; Helena Zemlicková
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

10.  Imipenem-resistant Gram-negative bacterial isolates carried by persons upon medical examination in Korea.

Authors:  So Yeon Kim; Sang Yop Shin; Ji-Young Rhee; Kwan Soo Ko
Journal:  J Microbiol       Date:  2017-07-18       Impact factor: 3.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.